Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Kun‐Liang Guan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1892-0174; OpenAlex author ID A5016834516. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper

Papers 2

  1. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Co-author DOI 10.1158/0008-5472.can-16-2594↗
  2. Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Last author DOI 10.1016/j.ccr.2013.02.005↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ken Fujimura · 1 shared paper, 2017 · strength 0.06
  2. Michael Bouvet · 1 shared paper, 2017 · strength 0.06
  3. Ján Strnádel · 1 shared paper, 2017 · strength 0.06
  4. Jonathan A. Kelber · 1 shared paper, 2017 · strength 0.06
  5. Richard L. Klemke · 1 shared paper, 2017 · strength 0.06
  6. Di Zhao · 1 shared paper, 2013 · strength 0.03
  7. Qun‐Ying Lei · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.